Notably, overall survival of PDA patients who had alterations in the genes for CD45 (PTPRC) and CD11b (ITGAM) was significantly lower than the survival of all patients with PDA (CBioportal.org query, Supplemental Figure 5S) (78, 79). This evidence concerns the gene PTPRC and Patent ductus arteriosus.